HomeBUSINESS
BUSINESS

Shionogi Hooks Up with Purdue on Naldemedine Commercialization in US
(Dec.20.2016)

Shionogi said on December 19 that it has forged a strategic business alliance with Purdue Pharma L.P., a privately held US drug company, for the commercialization of naldemedine, a novel peripherally-acting mu-opioid receptor antagonist, in the US ...
(LOG IN FOR FULL STORY)

News Calendar